CS117192A3 - SUBSTITUTED 3-(PYRIDINYLAMINO)INDOLES AND BENZO/b/THIOPHENES, PROCESS OFPREPARING SAID COMPOUNDS AND THEIR USE AS MEDICAMENTS - Google Patents

SUBSTITUTED 3-(PYRIDINYLAMINO)INDOLES AND BENZO/b/THIOPHENES, PROCESS OFPREPARING SAID COMPOUNDS AND THEIR USE AS MEDICAMENTS Download PDF

Info

Publication number
CS117192A3
CS117192A3 CS921171A CS117192A CS117192A3 CS 117192 A3 CS117192 A3 CS 117192A3 CS 921171 A CS921171 A CS 921171A CS 117192 A CS117192 A CS 117192A CS 117192 A3 CS117192 A3 CS 117192A3
Authority
CS
Czechoslovakia
Prior art keywords
compound
lower alkyl
group
formula
amino
Prior art date
Application number
CS921171A
Other languages
Czech (cs)
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Lawrence Leo Martin
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of CS117192A3 publication Critical patent/CS117192A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS921171A 1991-04-17 1992-04-16 SUBSTITUTED 3-(PYRIDINYLAMINO)INDOLES AND BENZO/b/THIOPHENES, PROCESS OFPREPARING SAID COMPOUNDS AND THEIR USE AS MEDICAMENTS CS117192A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (1)

Publication Number Publication Date
CS117192A3 true CS117192A3 (en) 1992-11-18

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
CS921171A CS117192A3 (en) 1991-04-17 1992-04-16 SUBSTITUTED 3-(PYRIDINYLAMINO)INDOLES AND BENZO/b/THIOPHENES, PROCESS OFPREPARING SAID COMPOUNDS AND THEIR USE AS MEDICAMENTS

Country Status (25)

Country Link
US (1) US5177088A (zh)
EP (1) EP0509402B1 (zh)
JP (1) JP2617650B2 (zh)
KR (1) KR100254027B1 (zh)
AT (1) ATE161840T1 (zh)
AU (1) AU655253B2 (zh)
BG (1) BG61034B1 (zh)
CA (1) CA2066332C (zh)
CS (1) CS117192A3 (zh)
DE (1) DE69223837T2 (zh)
DK (1) DK0509402T3 (zh)
ES (1) ES2111580T3 (zh)
FI (1) FI105096B (zh)
GR (1) GR3026317T3 (zh)
HU (1) HU215113B (zh)
IE (1) IE921235A1 (zh)
IL (1) IL101599A (zh)
MX (1) MX9201759A (zh)
NO (1) NO180486C (zh)
NZ (1) NZ242359A (zh)
PL (1) PL168905B1 (zh)
RO (1) RO109847B1 (zh)
RU (1) RU2060254C1 (zh)
TW (1) TW200477B (zh)
ZA (1) ZA922807B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
ATE199147T1 (de) * 1995-06-06 2001-02-15 Aventis Pharma Inc Benzisoxazol- und indazol- derivate als antipsychotika
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
HUP0000783A2 (hu) * 1996-12-27 2001-04-28 Hoechst Marion Roussel, Inc. N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
EP1216244B1 (en) * 1999-09-14 2003-08-13 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
DE10029371A1 (de) 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
AU2005250116B2 (en) 2004-06-01 2011-01-20 F. Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
CA2632284A1 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 3-amino-2-arylpropyl azaindoles and uses thereof
CN101316818B (zh) 2005-11-30 2011-08-31 弗·哈夫曼-拉罗切有限公司 3-氨基-1-芳基丙基吲哚类和氮杂取代的吲哚类
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
RU2460525C2 (ru) * 2008-01-04 2012-09-10 Эл Джи Лайф Сайенсиз Лтд. Производные индола и индазола, обладающие консервирующим действием по отношению к клеткам, тканям и органам

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049779B1 (en) * 1980-09-18 1984-10-31 Asahi Kasei Kogyo Kabushiki Kaisha 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
KR100254027B1 (ko) 2000-05-01
KR920019777A (ko) 1992-11-20
JP2617650B2 (ja) 1997-06-04
ATE161840T1 (de) 1998-01-15
FI105096B (fi) 2000-06-15
NO180486C (no) 1997-04-30
FI921693A0 (fi) 1992-04-15
TW200477B (zh) 1993-02-21
RU2060254C1 (ru) 1996-05-20
IL101599A (en) 1996-05-14
PL168905B1 (pl) 1996-05-31
IE921235A1 (en) 1992-10-21
BG96202A (bg) 1993-12-24
ES2111580T3 (es) 1998-03-16
NZ242359A (en) 1995-03-28
HU215113B (hu) 1998-12-28
NO921505D0 (no) 1992-04-15
FI921693A (fi) 1992-10-18
AU655253B2 (en) 1994-12-08
PL294239A1 (en) 1993-06-14
CA2066332C (en) 2003-07-29
DE69223837D1 (de) 1998-02-12
BG61034B1 (bg) 1996-09-30
NO921505L (no) 1992-10-19
EP0509402A1 (en) 1992-10-21
JPH05117266A (ja) 1993-05-14
DE69223837T2 (de) 1998-06-25
GR3026317T3 (en) 1998-06-30
NO180486B (no) 1997-01-20
US5177088A (en) 1993-01-05
RO109847B1 (ro) 1995-06-30
ZA922807B (en) 1992-11-25
EP0509402B1 (en) 1998-01-07
MX9201759A (es) 1992-10-01
DK0509402T3 (da) 1998-09-07
IL101599A0 (en) 1992-12-30
CA2066332A1 (en) 1992-10-18
HUT62572A (en) 1993-05-28
HU9201297D0 (en) 1992-07-28
AU1512192A (en) 1992-10-22

Similar Documents

Publication Publication Date Title
CS117192A3 (en) SUBSTITUTED 3-(PYRIDINYLAMINO)INDOLES AND BENZO/b/THIOPHENES, PROCESS OFPREPARING SAID COMPOUNDS AND THEIR USE AS MEDICAMENTS
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
JP3057109B2 (ja) 新規インドール誘導体
US7238696B2 (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
JP2009541461A (ja) 5−ht6モジュレーターとしてのインドール
CZ284371B6 (cs) Nové (R)-5-karbamoyl-8-fluor-3-N,N-disubstituované amino-3,4-dihydro-2H-1-benzopyrany
TW200906407A (en) Substituted heterocyclic ethers and their use in CNS disorders
KR101107807B1 (ko) 5-ht(5a) 수용체 길항제로서의 2-아미노퀴놀린
US6329366B1 (en) Pharmaceutical compounds
US5328920A (en) Substituted (pyridinylamino)-indoles
AU7795598A (en) Carboxamides useful as 5-HT1F agonists
EP0534343B1 (en) Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo(b) thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments
US5246947A (en) Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression
US5229401A (en) Substituted pyridinylamino benzo[b]thiophene compounds
JPH09512025A (ja) 5ht▲下2c▼および5ht▲下2b▼アンタゴニストとしての三環式誘導体
US6022880A (en) Substituted pyridylamino indoles
JP2002510675A (ja) うつ病治療用のn−アリールオキシエチル−インドリル−アルキルアミン(5−ht1a受容体活性薬)
EP1859798B1 (en) N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
EP1068199B1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
US6150533A (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
JP2000517318A (ja) ドパミンd2作動薬としての4―アミノエトキシインドロン誘導体
MXPA00009808A (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression